GlaxoSmithKline and Insilico Medicine are partnering to explore how the latter’s artificial intelligence…
Welcome to this week's FiercePharmaAsia report, which includes stories about Celgene's $1.4 billion…
Incyte will pay around $120 million upfront with an $80 million share buy-in…
Two high-level biopharma executives are among seven people who face U.S. Securities and…
image: The expansion of Dr. Bayewitch’s role is part of Insilico’s evolving BD strategy,…
image: Insilico collaborates with Boehringer Ingelheim on artificial intelligence system for target discovery.
…
image: Insilico collaborates with Teva.
…